Samir Shah | Global Head, IR |
Vasant Narasimhan | CEO |
Marie-France Tschudin | President, Novartis Pharmaceuticals |
Susanne Schaffert | President, Novartis Oncology |
Harry Kirsch | CFO |
Richard Saynor | CEO, Sandoz |
John Tsai | Head, Global Drug Development & Chief Medical Officer |
Graham Parry | Bank of America Merrill Lynch |
Richard Parkes | BNP Paribas |
Laura Sutcliffe | UBS |
Andrew Baum | Citigroup |
Simon Baker | Redburn |
Kerry Holford | Berenberg |
Keyur Parekh | Goldman Sachs Group |
Wimal Kapadia | Sanford C. Bernstein & Co. |
Matthew Weston | Crédit Suisse |
Richard Vosser | JPMorgan Chase & Co. |
Emmanuel Papadakis | Deutsche Bank |
Mark Purcell | Morgan Stanley |
Florent Cespedes | Societe Generale |
Peter Welford | Jefferies |
Seamus Fernandez | Guggenheim Securities |
Good morning and good afternoon. And welcome to the Novartis Q4 and Full Year 2021 Results Release Conference Call and Live Webcast. [Operator Instructions]. With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations.